natgillin/translations-raw huggingface dataset:
• inform the patients about potential adverse reactions related to liver that could be caused by the use of Ulipristal Acetate Gedeon Richter. 
• informirati bolesnice o mogućim nuspojavama povezanima s jetrom koje bi mogle biti uzrokovane uzimanjem lijeka Ulipristal Acetate Gedeon Richter.
Ulipristal Acetate Gedeon Richter treatment is to be initiated and supervised by physicians experienced in the diagnosis and treatment of uterine fibroids. 
Liječenje lijekom Ulipristal Acetate Gedeon Richter trebaju započeti i nadzirati liječnici s iskustvom u dijagnosticiranju i liječenju fibroida maternice.
Depending on the result of these tests your doctor will decide if treatment with Ulipristal Acetate Gedeon Richter is suitable for you. 
Ovisno o rezultatima tih pretraga, Vaš liječnik odlučit će je li liječenje lijekom Ulipristal Acetate Gedeon Richter prikladno za Vas.
In addition, hormonal contraceptives and progestagens (e.g. norethindrone or levonorgestrel) are also likely to make Ulipristal Acetate Gedeon Richter less effective. 
Osim toga hormonski kontraceptivi i progestageni (primjerice, noretindron ili levonorgestrel) također će vjerojatno smanjiti djelotvornost lijeka Ulipristal Acetate Gedeon Richter.
Ulipristal Acetate Gedeon Richter is contraindicated in patients with hepatic disorder (see section 4.3 and 4.4). 
Lijek Ulipristal Acetate Gedeon Richter kontraindiciran je u bolesnica s poremećajem jetre (vidjeti dijelove 4.3 i 4.4).
If you have been prescribed several courses of Ulipristal Acetate Gedeon Richter 3-month treatment, you should start each course at the earliest during the second menstrual period following the previous treatment completion. 
Vam je propisano nekoliko ciklusa 3-mjesečnog liječenja lijekom Ulipristal Acetate Gedeon Richter, svaki ciklus trebate početi najranije tijekom razdoblja druge menstruacije koja nastupi nakon završetka prethodnog ciklusa liječenja.
In the active comparator controlled study the rates were 24% (10.5% moderate or severe) for ulipristal acetate and 60.4% (39.6% moderate or severe) for leuprorelin-treated patients. 
(10,5% umjereno ili teško) za ulipristalacetat i 60,4% (39,6% umjereno ili teško) za bolesnike liječene leuprorelinom.
2nd TEST (4 weeks after starting treatment) 3rd TEST (8 weeks after starting treatment) 4th TEST (12 weeks after starting treatment) 5th TEST (2- 4 weeks after stopping Ulipristal Acetate Gedeon Richter treatment) 
2. PRETRAGA (4 tjedna nakon početka liječenja) 3. PRETRAGA (8 tjedana nakon početka liječenja) 4. PRETRAGA (12 tjedana nakon početka liječenja)
QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of ulipristal acetate. 
KVALITATIVNI I KVANTITATIVNI SASTAV Jedna tableta sadrži 5 mg ulipristalacetata.
Therefore, do not breast-feed your baby while taking Ulipristal Acetate Gedeon Richter. 
Stoga nemojte dojiti svoju bebu dok uzimate Esmyu.
Most patients treated with ulipristal acetate stopped bleeding within the first week of treatment (amenorrhea). 
Većina bolesnica liječenih ulipristalacetatom prestala je krvariti unutar prvog tjedna liječenja
Ulipristal Acetate Gedeon Richter is likely to make some hormonal contraceptives less effective. 
Vjerojatno je da će Ulipristal Acetate Gedeon Richter smanjiti djelotvornost nekih hormonskih kontraceptiva.
If you do become pregnant during Ulipristal Acetate Gedeon Richter treatment, you should stop taking Ulipristal Acetate Gedeon Richter immediately and contact your doctor or pharmacist. 
Ako zatrudnite tijekom liječenja lijekom Ulipristal Acetate Gedeon Richter, odmah prekinite uzimanje lijeka i obratite se svom liječniku ili ljekarniku.
Ulipristal Acetate Gedeon Richter may cause mild dizziness (see section 4 “Possible side effects”). 
Ulipristal Acetate Gedeon Richter može uzrokovati blagu omaglicu (pogledajte dio 4 „Moguće nuspojave“).
4.5 Interaction with other medicinal products and other forms of interaction 
4.5 Interakcije s drugim lijekovima i drugi oblici interakcija Mogućnost utjecaja drugih lijekova na djelovanje ulipristalacetata:
Before you start treatment with Ulipristal Acetate Gedeon Richter blood tests will be undertaken to find out how well your liver is working. 
- Prije nego što počnete uzimati lijek Ulipristal Acetate Gedeon Richter, obavit ćete krvne pretrage kako bi se utvrdilo kako radi Vaša jetra.
• inform the patients not to take Ulipristal Acetate Gedeon Richter in case of liver problems. 
• informirati bolesnice da ne uzimaju lijek Ulipristal Acetate Gedeon Richter ako imaju probleme s jetrom.
You should know that most women have no menstrual bleeding (period) during the treatment and for a few weeks afterwards. 
Što morate znati prije nego počnete uzimati Esmyu Trebate znati da većina žena nema menstrualno krvarenje (mjesečnicu) tijekom liječenja ovim lijekom te nekoliko tjedana nakon toga.
You should always start taking Ulipristal Acetate Gedeon Richter within the first week of your menstrual period. 
Lijek Ulipristal Acetate Gedeon Richter uvijek morate početi uzimati unutar prvog tjedna Vaše menstruacije.
Tell your doctor or pharmacist if you are taking any of the medicines listed below, as these medicines can affect Ulipristal Acetate Gedeon Richter or be affected by Ulipristal Acetate Gedeon Richter: - Certain medicines which are used to treat the heart (e.g. digoxin). 
Obavijestite svog liječnika ili ljekarnika ako uzimate bilo koji od lijekova u nastavku jer ovi lijekovi mogu utjecati na lijek Ulipristal Acetate Gedeon Richter ili Ulipristal Acetate Gedeon Richter može utjecati na njih:
In vitro data indicate that ulipristal acetate and its active metabolite do not inhibit CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4, or induce CYP1A2 at clinically relevant concentrations. 
CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1 te 3A4 ili induciraju CYP1A2 u klinički značajnim koncentracijama.
Keep this medicine out of the sight and reach of children. 
Kako čuvati Esmyu Lijek čuvajte izvan pogleda i dohvata djece.
Ulipristal Acetate Gedeon Richter can cause side effects although not everybody gets them. 
Lijek Ulipristal Acetate Gedeon Richter može uzrokovati nuspojave, iako se one neće javiti kod svakoga.
What Ulipristal Acetate Gedeon Richter is and what it is used for 
Što je Ulipristal Acetate Gedeon Richter i za što se koristi
Patients starting treatment course 2 or 4 
Bolesnice koje započinju 2.
If you stop taking Ulipristal Acetate Gedeon Richter Ulipristal Acetate Gedeon Richter is to be taken daily during treatment courses of up to 3 months continuously. 
Ulipristal Acetate Gedeon Richter se mora neprekidno svakodnevno uzimati tijekom ciklusa liječenja od po najduže 3 mjeseca.
Keep the blisters in the outer carton in order to protect from light. 
Blistere čuvajte u vanjskoj kutiji radi zaštite od svjetlosti.
breast discomfort - swelling due to fluid retention (oedema) - extreme tiredness (asthenia) - increase in blood cholesterol seen in blood tests, increase in blood fats (triglycerides) seen in blood tests. 
- ekstremni umor (astenija) - povišen kolesterol u krvi što je vidljivo u krvnim pretragama, povišene masnoće u krvi
Patient card 
Kartica za bolesnicu
SPECIAL STORAGE CONDITIONS Keep the blisters in the outer carton in order to protect from light. 
POSEBNE MJERE ČUVANJA Čuvati blistere u vanjskom pakiranju radi zaštite od svjetlosti.
Do not take Ulipristal Acetate Gedeon Richter - if you are allergic to ulipristal acetate or any of the other ingredients of Ulipristal Acetate 
Nemojte uzimati Esmyu - ako ste alergični na djelatnu(e) tvar(i) ili neki drugi sastojak lijeka Ulipristal Acetate Gedeon
Ulipristal Acetate Gedeon Richter contains the active substance ulipristal acetate. 
Ulipristal Acetate Gedeon Richter sadrži djelatnu tvar ulipristalacetat.
- If you are currently taking hormonal contraception (for example birth control pills) (see “Other medicines and Ulipristal Acetate Gedeon Richter”) you should use an alternative reliable barrier contraceptive method (such as a condom) while taking Ulipristal Acetate Gedeon Richter. 
(pogledajte „Drugi lijekovi i Ulipristal Acetate Gedeon Richter“), morate koristiti drugu pouzdanu metodu barijerne kontracepcije (poput kondoma) dok uzimate Esmyu.
Following oral administration of a single dose of 5 or 10 mg, ulipristal acetate is rapidly absorbed, with a Cmax of 23.5 ± 14.2 ng/ml and 50.0 ± 34.4 ng/ml occurring approximately 1 h after ingestion, and with an AUC0-∞ of 61.3 ± 31.7 ng.h/ml and 134.0 ± 83.8 ng.h/ml, respectively. 
23,5 ± 14,2 ng/ml i 50,0 ± 34,4 ng/ml koja se događa približno 1 sat nakon gutanja, i s AUC0-∞ od 61,3 ± 31,7 ng/ml odnosno s 134,0 ± 83,8 ng.h/ml.
If you forget to take Ulipristal Acetate Gedeon Richter If you miss a dose by less than 12 hours, take it as soon as you remember. 
Ako propustite dozu za manje od 12 sati, uzmite je čim se sjetite.
Ulipristal Acetate Gedeon Richter passes into the breast milk. 
Ulipristal Acetate Gedeon Richter se izlučuje u majčino mlijeko.
- If you suffer from severe asthma, treatment with Ulipristal Acetate Gedeon Richter may not be suitable for you. 
Ako patite od teškog oblika astme, liječenje lijekom Ulipristal Acetate Gedeon Richter možda neće biti prikladno za Vas.
If a patient during treatment shows signs or symptoms compatible with liver injury (fatigue, asthenia, nausea, vomiting, right hypochondrial pain, anorexia, jaundice), treatment should be stopped and the patient should be investigated immediately, and liver function tests performed. 
astenija, mučnina, povraćanje, bol u desnom hipohondriju, anoreksija, žutica itd.), liječenje je potrebno prekinuti, odmah je pregledati i obaviti testove jetrene funkcije.
Uncommon (may affect up to 1 in 100 people) side effects: - drug allergy - anxiety - mood swings - dizziness - dry mouth, constipation - hair loss, dry skin, increased sweating - back pain - leakage of urine - bleeding from the womb (uterine bleeding), vaginal discharge, abnormal vaginal bleeding, 
Manje česte nuspojave (mogu se javiti u manje od 1 na 100 osoba): - alergija na lijek - tjeskoba - promjene raspoloženja - omaglica - suha usta, zatvor - gubitak kose, suha koža, pojačano znojenje
Most findings in general toxicity studies were related to its action on progesterone receptors (and at higher concentrations on glucocorticoid receptors), with antiprogesterone activity observed at exposures similar to therapeutic levels. 
(te pri višim koncentracijama na glukokortikoidne receptore) s aktivnošću antiprogesterona primijećenom pri izloženosti sličnoj onoj pri terapijskim razinama.
INFORMATION IN BRAILLE Ulipristal Acetate Gedeon Richter 
16. PODACI NA BRAILLEOVOM PISMU Ulipristal Acetate Gedeon Richter
In study 4, 61.9% and 72.7% of patients were in amenorrhea at the end of both treatment course 1 and 2 combined (5 mg dose and 10 mg dose, respectively, p=0.032); 48.7 % and 60.5 % were in amenorrhea at the end of all four treatment courses combined (5 mg dose and 10 mg dose, 
U ispitivanju 4, u 61,9% odnosno 72,7% bolesnica amenoreja je postignuta na kraju prvog i drugog ciklusa liječenja zajedno (doza od 5 mg, odnosno 10 mg, p=0,032).
Administration of ulipristal acetate (10 mg tablet) together with the proton pump inhibitor esomeprazole (20 mg daily for 6 days) resulted in approximately 65% lower mean Cmax, a delayed tmax (from a median of 0.75 hours to 1.0 hours) and 13% higher mean AUC. 
Primjena ulipristalacetata (tablete od 10 mg) skupa s inhibitorom protonske pumpe esomeprazolom (20 mg dnevno tijekom 6 dana) rezultirala je približno 65% nižom prosječnom Cmax te odgođenim tmax
Stop using Ulipristal Acetate Gedeon Richter and immediately contact a doctor if you experience any of the following symptoms: 
Prestanite uzimati Esmyu i odmah obavijestite liječnika ako osjetite neki od sljedećih simptoma:
The efficacy of repeated treatment courses fixed doses of ulipristal acetate 5 mg or 10 mg once daily was evaluated in two Phase 3 studies assessing up to 4 intermittent 3-month treatment courses in patients with heavy menstrual bleeding associated with uterine fibroids. 
Djelotvornost ponovljenih ciklusa liječenja s fiksnom dozom ulipristalacetata od 5 mg ili 10 mg jednom dnevno procijenjena je u dva ispitivanja faze III u kojima su se ocjenjivala do 4 intermitentna
Other medicines and Ulipristal Acetate Gedeon Richter Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. 
Obavijestite svog liječnika ili ljekarnika ako uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove.
PHARMACEUTICAL PARTICULARS 6.1 List of excipients Microcrystalline cellulose 
6.1 Popis pomoćnih tvari celuloza, mikrokristalična manitol karmelozanatrij, umrežena talk magnezijev stearat
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: DD month YYYY Date of latest renewal: DD month YYYY 
DATUM PRVOG ODOBRENJA/DATUM OBNOVE ODOBRENJA
You should nonetheless ask your doctor or pharmacist for advice if you take more Ulipristal Acetate Gedeon Richter than you should. 
Bez obzira na to morate pitati svog liječnika ili ljekarnika za savjet ako ste uzeli više lijeka Ulipristal
Hot flush 
navale vrućine
The educational material shall consist of the following: 
Edukacijski materijal sastojat će se od sljedećeg: • Edukacijskog materijala za propisivače (ginekologe) koji sadrži:
If endometrial thickening is noted, which persists after return of menstruations during off-treatment periods or beyond 3 months following the end of treatment courses, and/or an altered bleeding pattern is noted (see section "Bleeding pattern" below), investigation including endometrial biopsy should be performed in order to exclude other underlying conditions, including endometrial malignancy. 
Ako se opazi zadebljanje endometrija koje perzistira nakon ponovne pojave menstruacije tijekom razdoblja bez liječenja ili dulje od 3 mjeseca nakon završetka ciklusa liječenja i/ili ako se opazi promijenjeni uzorak krvarenja (vidjeti dio “Uzorak krvarenja“ dalje u tekstu), treba provesti pretrage,
NAME OF THE MARKETING AUTHORISATION HOLDER Gedeon Richter 
NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Gedeon Richter
Ulipristal Acetate Gedeon Richter 5 mg tablets Ulipristal acetate 
Ulipristal Acetate Gedeon Richter 5 mg tablete ulipristalacetat
- If you have liver or kidney disease tell your doctor or pharmacist before taking Ulipristal Acetate Gedeon Richter. 
Ako imate bolest jetre ili bubrega, obavijestite svog liječnika ili ljekarnika prije nego uzmete
• if a patient during treatment shows signs or symptoms compatible with liver injury, treatment should be stopped, and the patient should be investigated immediately, and liver function tests performed. 
• ako bolesnica tijekom liječenja pokaže znakove ili simptome koji odgovaraju oštećenju jetre,
ULIPRISTAL ACETATE GEDEON RICHTER 5 mg TABLETS PATIENT CARD 
ULIPRISTAL ACETATE GEDEON RICHTER 5 mg TABLETE KARTICA ZA BOLESNICU
What Ulipristal Acetate Gedeon Richter contains - The active substance is ulipristal acetate. 
Sadržaj pakiranja i druge informacije Što Ulipristal Acetate Gedeon Richter sadrži - Djelatna tvar je ulipristalacetat.
Although a majority of women taking a therapeutic dose of ulipristal acetate have anovulation, a non hormonal contraceptive method is recommended during treatment (see sections 4.4 and 4.5). 
tijekom liječenja se preporučuje nehormonska metoda kontracepcije (vidjeti dijelove 4.4 i 4.5).
Therefore, hormonal contraceptives are not recommended and you should use an alternative reliable barrier contraceptive method, such as a condom, during Ulipristal Acetate Gedeon Richter treatment. 
Gedeon Richter treba koristiti alternativnu pouzdanu metodu barijerne kontracepcije poput kondoma.
You should avoid drinking grapefruit juice while on treatment with Ulipristal Acetate Gedeon Richter. 
Ulipristal Acetate Gedeon Richter s hranom i pićem Tijekom liječenja lijekom Ulipristal Acetate Gedeon Richter izbjegavajte piti sok od grejpa.
Do not take Ulipristal Acetate Gedeon Richter if you have liver problems.Tell your doctor if you know that you have problems with your liver or if you have any doubts about the condition of your liver. 
Recite svojem liječniku ako znate da imate problema s jetrom ili ako niste sigurni u stanje svoje jetre.
Following administration of the moderate CYP3A4 inhibitor erythromycin propionate (500 mg twice daily for 9 days) to healthy female volunteers, Cmax and AUC of ulipristal acetate increased 1.2 and 
Nakon primjene umjerenog inhibitora CYP3A4 eritromicin propionata (500 mg dvaput dnevno tijekom 9 dana) kod zdravih ženskih dobrovoljaca, Cmax i AUC ulipristalacetata povećali su se za 1,2 odnosno 2,9 puta, a AUC aktivnog metabolita ulipristalacetata povećala se za 1,5 puta dok se Cmax aktivnog metabolita smanjila (za 0,52 puta).
NAME OF THE MEDICINAL PRODUCT Ulipristal Acetate Gedeon Richter 5 mg tablets 
NAZIV LIJEKA Ulipristal Acetate Gedeon Richter 5 mg tablete
Acne 
- akne
• the need to inform the pathologist that patients were treated with Ulipristal Acetate Gedeon Richter if biopsy/surgical samples are to be sent for analysis. 
• potrebu za informiranjem patologa da su bolesnice bile liječene lijekom Ulipristal Acetate
How to take Ulipristal Acetate Gedeon Richter 
Ulipristal Acetate Gedeon Richter.
• Educational material for prescribers (gynaecologists) which contains: o Cover letter o SmPC o Physician's guide to prescribing Ulipristal Acetate Gedeon Richter 
o Popratno pismo o Sažetak opisa svojstava lijeka o Vodič za liječnika za propisivanje lijeka Ulipristal Acetate Gedeon Richter
Headache* 
I DOHVATA
Breastfeeding 
omaglica
Common (may affect up to 1 in 10 people) side effects: - headache - spinning sensation (vertigo) - stomach ache, feeling sick (nausea) - acne - muscle and bone (musculoskeletal) pain - sac of fluid within the ovaries (ovarian cyst), breast tenderness/pain, lower abdominal (pelvic) 
- bol u mišićima i kostima (koštano-mišićna bol) - vrećica tekućine unutar jajnika (cista na jajnicima), osjetljivost/bol u dojkama, bol u donjem dijelu trbuha (zdjelici)
Marketing Authorisation Holder Gedeon Richter Plc. 
NOSITELJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Gedeon Richter Plc.
MARKETING AUTHORISATION HOLDER Gedeon Richter Plc. 
Nositelj odobrenja za stavljanje lijeka u promet Gedeon Richter Plc.
Physician's guide to prescribing 
OZNAČIVANJE I UPUTA O LIJEKU
See also section 2 Warnings and precautions. 
Upozorenja i mjere opreza.
Menstrual periods generally return within 4 weeks after the end of each treatment course. 
Vaša mjesečnica trebala bi se ponovno pojaviti unutar 4 tjedna nakon prekida liječenja lijekom
pain, hot flushes - tiredness (fatigue) - weight increase. 
- premorenost (umor) - porast tjelesne težine.
Treatments should only be initiated when menstruation has occurred: - The first treatment course should start during the first week of menstruation. 
- Prvi ciklus liječenja treba početi tijekom prvog tjedna menstruacije.
Your period should generally return within 4 weeks after treatment with Ulipristal Acetate Gedeon Richter is stopped. 
5. PRETRAGA (2 do 4 tjedna nakon prestanka uzimanja lijeka Ulipristal Acetate Gedeon Richter)
Rare (may affect up to 1 in 1,000 people) side effects: - nosebleed - indigestion, bloating - break of sac of fluid within the ovaries (ovarian cyst ruptured) - breast swelling. 
Rijetke nuspojave (mogu se javiti u manje od 1 na 1000 osoba): - krvarenje iz nosa - probavne tegobe, nadutost
If you take more Ulipristal Acetate Gedeon Richter than you should Experience with Ulipristal Acetate Gedeon Richter when several doses are taken at once is limited. 
Nisu prijavljeni ozbiljni štetni učinci prilikom uzimanja više doza lijeka Ulipristal Acetate Gedeon Richter istovremeno.
• inform the patients about the need for monitoring of liver function before starting each treatment course, monthly during treatment and within a few weeks after the treatment has stopped. 
• informirati bolesnice da moraju pratiti jetrenu funkciju prije početka svakog ciklusa liječenja,
How to store Ulipristal Acetate Gedeon Richter 
Drugi lijekovi i Ulipristal Acetate Gedeon Richter
If endometrial thickening is noted, which persists after return of menstruations during off-treatment periods or beyond 3 months following the end of treatment courses, and/or an altered bleeding pattern is noted, investigation including endometrial biopsy should be performed in order to exclude other underlying conditions, including endometrial malignancy. 
Ako se opazi zadebljanje endometrija koje perzistira nakon ponovne pojave menstruacije tijekom razdoblja bez liječenja ili dulje od 3 mjeseca nakon završetka ciklusa liječenja i/ili ako se opazi promijenjeni uzorak krvarenja,
ANNEX II A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT 
PRILOG II. A. PROIZVOĐAČ(I) ODGOVORAN(NI) ZA PUŠTANJE SERIJE LIJEKA U PROMET
• vomiting 
• mučninu • povraćanje
Dyspepsia Flatulence 
Navale vrućine (valunzi)
Study 3 
PRILOG III.
NAME OF THE MEDICINAL PRODUCT Ulipristal Acetate Gedeon Richter 5 mg tablets Ulipristal acetate 
Uputa o lijeku: Informacije za korisnika Ulipristal Acetate Gedeon Richter 5 mg tablete ulipristalacetat
Macrogol 8000 
makrogol 8000
A double dose should not be taken on the same day. 
U istom danu se ne smije uzeti dvostruka doza.
Age, gender, race, body weight 
Dob, spol, rasa, tjelesna težina
It helps your body make better use of the insulin it produces. 
On pomaže tijelu da bolje iskoristi inzulin kojeg stvara.
Your doctor will tell you how much Incresync you need to take and if you need to change the amount of other medicines you take. 
Liječnik će Vam reći koliko Incresynca morate uzimati i trebate li promijeniti količinu drugih lijekova koje uzimate.
Combinations not studied 
Kombinacije koje nisu ispitane
ATC code: A10BD09. 
ATK oznaka: A10BD09.
Uncommon: - Difficulty sleeping 
• teškoće sa spavanjem
Distribution The estimated volume of distribution in humans is 19 L. 
Procijenjeni volumen distribucije u ljudi je 19 l.
Your blood sugar could fall below the normal level, but can be increased again by taking sugar. 
Šećer u krvi može pasti ispod normalne razine, ali može se ponovno povisiti uzimanjem šećera.
The relevance of this finding is unknown. 
Značaj ovog nalaza nije poznat.
Take this leaflet or some tablets with you so that your doctor knows exactly what you have taken. 
Ponesite sa sobom ovu uputu ili nekoliko tableta kako bi liječnik točno znao što ste uzeli.
The magnitude of these reductions was not considered to be clinically relevant. 
Smatra se da veličina tih sniženja nije klinički značajna.
- if you have blood in your urine that your doctor has not checked. 
• ako imate krv u mokraći koju liječnik nije provjerio.
Your doctor will check whether Incresync is working 3 to 6 months after you start taking it. 
Liječnik će provjeriti djelovanje lijeka Incresync 3 do 6 mjeseci nakon što ga počnete uzimati.
Change at Week 52 (n=303) 
Promjena u 52. tjednu (n=303)
Before you start taking this medicine you will have a blood sample taken to check your liver and kidney function. 
Prije nego što počnete uzimati ovaj lijek uzet će Vam uzorak krvi da bi se provjerila funkcija Vaše jetre i bubrega.
Other medicines and Incresync 
Drugi lijekovi i Incresync
This medicinal product does not require any special temperature storage conditions. 
Ovaj lijek ne zahtijeva posebne temperaturne uvjete čuvanja.
- if you are elderly and are taking insulin, because you may have an increased risk of heart problems. 
• ako ste starije dobi i uzimate inzulin, jer možda imate povećani rizik srčanih problema.
Incresync should not be used in combination with insulin, as the safety and efficacy of this combination have not been established. 
Incresync se ne smije koristiti u kombinaciji s inzulinom jer sigurnost i djelotvornost te kombinacije nisu ustanovljene.
The relevance of such a mechanism in humans is unclear. 
Značaj takvog mehanizma u ljudi nije jasan.
You may experience visual disturbances while taking this medicine. 
Možete imati smetnje vida dok uzimate ovaj lijek.